In analyzing the forecast for cervix uteri malignant neoplasms mortality in Chile, starting from the actual data in 2023, we see a consistent value at 6.8 female deaths per hundred thousand women. This remains stable for 2024 and 2025. A slight year-on-year increase of 1.47% occurs between 2025 and 2026, reaching 6.9, which persists through to 2028. The overall compound annual growth rate (CAGR) over this five-year period is marginal, reflecting a very slow upward trend.
Future trends to watch for include the impact of advancements in medical technology, vaccination programs against HPV, and public health initiatives aimed at early detection and prevention. These factors could potentially alter the forecasted trend, either stabilizing or even reducing the mortality rate in the long term.
Key Points:
• Stable mortality rate from 2023 to 2025
• Slight increase from 2026 onwards
• Minimal overall growth rate over the five-year period
• Importance of monitoring medical and public health advancements.
